| 6-OHDA | 6-Hydroxydopamine |
| AA | Arachidonic acid |
| APC | Adenoma Prevention with Celecoxib |
| APPROVe | Adenomatous Polyp Prevention on Vioxx |
| CABG-II | Coronary Artery Bypass Surgery |
| COVID-19 | Coronavirus disease 2019 |
| COX | Cyclooxygenase |
| EMEA | European Medicines Agency |
| MCI | Mild cognitive impairment |
| MDR1 | Multi-drug resistance 1 |
| MRSA | Methicillin-resistant Staphylococcus aureus |
| NSCLC | Non-small-cell lung cancer |
| OA | Osteoarthritis |
| PG | Prostaglandin |
| PTGS | Prostaglandin-endoperoxide synthase |
| RA | Rheumatoid arthritis |
| T2DM | Type 2 diabetes mellitus |
| tNSAIDs | Traditional non-steroidal anti-inflammatory drugs |
| TxA2 | Thromboxane A2 |
| VIGOR | Vioxx Gastrointestinal Outcomes Research |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.